Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.441EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.135EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.376EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.607EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.158EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.602EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.13 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.358EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.159EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.141EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.591EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.468EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.131 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.586EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.366EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.380EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.148EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.100EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used